Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB)

106 filings reported holding YMAB - Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share as of Q3 2023.
Y-mAbs Therapeutics, Inc. - Common Stock, $0.0001 par value per share (YMAB) has 98 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 19,680,958 shares of 45,101,565 outstanding shares and own 44% of the company stock.
Largest 10 shareholders include BlackRock Inc. (2,473,356 shares), VANGUARD GROUP INC (2,231,908 shares), Sofinnova Investments, Inc. (2,194,278 shares), Polar Capital Holdings Plc (2,103,298 shares), D. E. Shaw & Co., Inc. (1,349,210 shares), ACADIAN ASSET MANAGEMENT LLC (811,261 shares), STATE STREET CORP (741,098 shares), GEODE CAPITAL MANAGEMENT, LLC (710,833 shares), JACOBS LEVY EQUITY MANAGEMENT, INC (530,439 shares), and CITADEL ADVISORS LLC (414,307 shares).
This table shows the top 98 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.